Kolexia
Hebbar Mohamed Médecine interne
Hebbar Mohamed
Médecine interne
Hôpital Huriez
Lille, France
107 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Métastase tumorale Tumeurs du foie Adénocarcinome Tumeurs du côlon Carcinomes Tumeurs du pancréas Carcinome hépatocellulaire Récidive tumorale locale

Collaborateurs

Voir plus
Truant Stephanie
Truant Stephanie
Hôpital Huriez, Lille, France
Pruvot Francois-Rene
Pruvot Francois-Rene
Hôpital Huriez, Lille, France
Smith Denis
Smith Denis
Hôpital Saint-André, Bordeaux, France
Turpin Anthony
Turpin Anthony
Hôpital Huriez, Lille, France

Industries

Voir plus
Novartis
2 collaboration(s)
Dernière en 2018
Bayer
1 collaboration(s)
Dernière en 2018
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
SATURNE: A Double-Blind, Randomized, Phase II/III Study Comparing the Use of Chemoembolization Combined With Sunitinib Against Chemoembolization Combined With a Placebo in Patients With Hepatocellular Carcinoma (SATURNE)
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   17 mars 2022
Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab: Phase II, Multicentric Randomized Trial, Evaluating the Efficacy of Fluoropyrimidine-based Standard Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab
Essai Clinique (Unicancer)   07 janvier 2022
Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma: Multicentric Randomized Phase III Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus 5-fluorouracil, Leucovorin, Irinotecan and Oxaliplatin (mFolfirinox) in Patients With Resected Pancreatic Adenocarcinoma
Essai Clinique (Unicancer)   03 janvier 2022
Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients' Profiles With Oxaliplatin-Induced Peripheral Neuropathy.
Frontiers in pharmacology   04 novembre 2021
Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation   18 août 2020
Long-Term Prevalence of Sensory Chemotherapy-Induced Peripheral Neuropathy for 5 Years after Adjuvant FOLFOX Chemotherapy to Treat Colorectal Cancer: A Multicenter Cross-Sectional Study.
Journal of clinical medicine   27 juillet 2020
Liver transarterial chemoembolization and sunitinib for unresectable hepatocellular carcinoma: Results of the PRODIGE 16 study.
Clinics and research in hepatology and gastroenterology   21 juin 2020
Laparoscopic Partial ALPPS: Much Better Than ALPPS!
Annals of hepatology   13 avril 2020
Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal Cancer: The UNICANCER PRODIGE18 Randomized Clinical Trial.
JAMA oncology   19 décembre 2019
ASO Author Reflections: Fong's Score in the Era of Modern Strategies for Metastatic Colorectal Cancer.
Annals of surgical oncology   12 novembre 2019